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Abstract  
BACKGROUND: Psychoneuroimmunology (PNI) is the study of the interaction between psychological processes 
and the nervous and immune systems of the human body. The impact of psychological factors on the immune 
system and the role of this system in Coronary Artery Disease (CAD) are confirmed. Coronary Heart Disease 
(CHD) is arisen due to the failure of blood and oxygen to the heart tissues.  
AIM: The present study aimed to describe psychoneuroimmunological processes which contribute to CAD and 
CHD progression.  
METHOD: Such psychological risk factors like stress, depression and type D personality were investigated here. 
Psychoneuroimmunological pathways of all three mentioned risk factors were described for CAD.  
RESULTS: The studies review indicated that stress could be accompanied with myocardial ischemia and help to 
rupture. The depression involves in the transfer of stable atherosclerotic plaque to unstable, and type D 
personality is effective in the initial stages of a CAD.  
CONCLUSION: As more information on cardiovascular immunity becomes available, this will provide a better 
understanding and thus act as the foundation for the potential development of new treatment strategies for 
treatment of cardiovascular disorders. 
 
 
 
 
Introduction 
 
About 3 decades ago, some evidence was 
obtained that showed immune system interacts with 
the central nervous system and endocrine system, 
and such evidences indicated the impact of 
psychological factors on these systems. This 
awareness led to scientific findings and quick growth 
of a field called “psychoneuroimmunology” [1] [2]. The 
life of this field crystallised by the publication of brain, 
behaviour and immunity magazine in 1987 [1]. The 
psychoneuroimmunology studies the mutual relations 
between psychological factors, immunity and 
Neuroendocrine mechanisms as well as the 
application of the findings related to such relations in 
health and disease [2]. Also, it tries to present a 
picture of mutual relations between behaviour and 
immunity to explain mechanisms of the autonomic 
nervous system and Hypothalamic-Pituitary-Adrenal 
axis (HPA or HTPA axis) to relate central nervous 
system and immunity responses [2]. The relation 
between psychological factors and immunity system 
performance indices were seen from the common cold 
to the immune response to vaccination [3]. 
The impact of psychological interventions on 
immunity indicators was also seen in previous studies 
[4]. Therefore, psychological factors are related to 
some factors of immunity system that play a 
considerable role in the aetiology of coronary heart 
syndrome [5]. The brain influences immune responses 
through the HPA axis. This axis enhances/suppresses 
inflammatory responses through secretion of 
Corticotropin-releasing hormone (CRH) and 
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Adrenocorticotropic-releasing hormone, respectively 
from the hypothalamus and pituitary glands, and the 
secretion of cortisol from the adrenal. However, the 
paths between the brain and the immune system have 
not well been known [1]. 
The pathophysiological mechanisms effective 
among psychological factors and CAD progress can 
be related to immunological processes [6]. Recent 
research findings indicate that CAD is an important 
clinical appearance of psychoneuroimmunological 
mechanisms in heart disease progression and acute 
coronary syndromes. Kop classifies psychological 
risk-factors into three groups based on the duration, 
that is, their persistent or temporary presence [7]: 
Acute triggers such as psychological stress and anger 
[8], episodic factors with duration of few weeks to 2 
years such as depression and exhaustion [1], and 
Chronic Factors such as negative personality 
characteristics (enmity in Personality Type A and 
Personality Type D) and low socioeconomic level. 
The review studies which relate 
psychoneuroimmunological factors to coronary heart 
disease will provide helpful information to understand 
the psychoneuroimmunology of heart diseases. In the 
present paper, we will study the works which take 
advantage of the role of stress, depression and 
Personality Type D on the immune system while these 
factors lead to CAD progression. The results here 
allow physicians and specialists to realise the 
importance of the immune system as a relation 
between mind and cardiovascular system and pay 
more attention to mental health maintenance to 
prevent coronary artery disease. 
Therefore, the present paper will study the 
following items: 
- Stress effect process in the immune 
system and the incidence of coronary artery disease 
- Depression effect process in the 
immune system and the incidence of coronary artery 
disease 
- Personality Type D effect process in 
the immune system and the incidence of coronary 
artery disease 
And finally, to find a response to the below 
question: 
Do Stress, Depression and Type D 
Personality have different impacts on the immune 
system and incidence of coronary artery disease? 
 
 
Materials and Methods 
 
The present study was carried out as a review 
work. The search was conducted on the platforms 
associated with medical and psychiatric journals 
based on such keywords as stress, depression, type 
D personality, immune system and Coronary Artery 
Disease (CAD). This process took three months 
during which total of 38 papers and 108 authoritative 
abstracts were collected through Pubmed and Google 
Scholar. They ultimately were used to write and 
prepare for this review. 
 
 
Results 
 
Emotional stress is harmful to the heart. 
Statistical and clinical studies show that stress can 
increase the mortality associated with acute 
myocardial infarction. Of every seven adult Americans 
who suffer heart attacks, one person is experiencing 
stress. Tobacco and caffeine can increase heart rate 
up to 14 beats per minute, and if they are along with 
stress, the increase will reach to 38 beats per minute. 
Immune system responses to stress can potentially 
help to form Atherosclerotic plaque and avulsion or 
detachment of plaque. Most of the studies on 
psychoneuroimmunology show increased CD8+ cells, 
decreased CD4+ cells, increased blood viscosity and 
stimulated the immune system versus acute 
psychological challenges [7] [9]. 
Psychological stress activates the SNS, which 
regulates heart rate and release of catecholamines, 
and the HPA axis, which regulates the release of 
corticosteroids from the adrenal glands [10]. In acute 
psychological stress, catecholamines predominantly 
affect natural killer (NK) cell circulation. The 
relationship between acute stress, SNS and 
leucocytes are illustrated in Figure 1. In chronic 
stress, the activity of the HPA axis may decrease, 
leading to fatigue and increased activation of immune-
mediated inﬂammation [11] [12]. 
 
Figure 1: The relationship between acute stress, the sympathetic 
nervous system and the white blood cells 
 
Owen and Steptoe studied the associations 
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between NK cells, proinﬂammatory cytokine stress 
responsiveness and heart rate in humans. Increases 
in NK cell counts the following stress were positively 
associated with heart rate responses and individual 
differences in sympathetically-driven cardiac stress 
responses were associated with NK and 
proinﬂammatory cytokine responses to psychological 
stress [13]. 
An acute psychological stressor increases 
proinﬂammatory cytokines including mononuclear cell 
IL-1β gene expression and plasma interleukin-6 (IL-6). 
The increased IL-1β gene expression was positively 
correlated with heart rate and systolic blood pressure 
reactivity [14]. The cytokines also affect the brain and 
evoke feelings of malaise, sickness and tiredness [15] 
[16]. These cytokines can induce the proliferation and 
migration of smooth muscle cells by stimulating other 
growth factors that lead to coronary lesions [5] [17]. 
Mann suggested that the short-term expression of 
stress-activated cytokines within the heart may be an 
adaptive response to stress, whereas long-term 
expression of these molecules may be frankly 
maladaptive by producing cardiac decompensation 
[18]. 
Chronic psychosocial stressors increase both 
haemostatic factors (e.g. Factor VII) and acute phase 
proteins (e.g. Fibrinogen) [19]. Lonely individuals also 
displayed greater ﬁbrinogen response to stress [20]. 
Fibrinogen is thought to promote atherosclerosis by 
promoting platelet aggregation, enhancing the release 
of endothelial-derived growth factors, stimulating 
smooth muscle cell proliferation and increasing 
plasma and whole blood viscosity [14] [21]. Acute and 
chronic stress may activate the coagulation cascade 
and lead to thrombus formation and myocardial 
infarction (MI). There is robust evidence from 
epidemiological studies and meta-analyses that higher 
levels of acute phase proteins such as CRP and 
fibrinogen predict future cardiovascular death and are 
associated with low socioeconomic status. 
Psychological stress is associated with increased 
platelet activation and increases the risk of 
cardiovascular disease [20]. 
The relationship between depressive 
symptoms and coronary artery disease (CAD) is 
mediated in part by immune system parameters. This 
review describes research on the 
psychoneuroimmunological pathways accounting for 
the association between depression and CAD and 
addresses conceptual and methodological issues [21].  
The Immune-Cytokine Model of Depression 
(ICMD) is an entirely new concept for understanding 
the riddle of depression. This is the only model of 
depression to bridge the conceptual and diagnostic 
gap between physical and mental disorders 
[22]. ICMD views depression to be any number of 
chronic physical-biological disorders that have mental-
emotional symptoms. From the perspective of ICMD, 
depression isn't a disease, but rather a multifaceted 
sign of chronic immune system activation. During 
chronic immune system activation, greater than 
normal amounts of various cytokines are secreted. 
The cytokines produce the multifaceted signs and 
symptoms of depression [23].  
Cytokines are at the heart of the 
immunological basis of depression since they provoke 
a wide spectrum of neuropsychiatric symptoms when 
given to human volunteers. The profound effects of 
cytokines on mood though, and behaviour was first 
discovered in the early 1980's. For the first time in 
history, physicians had found molecules made by the 
human body which, when given to humans, produced 
all the symptoms necessary for the diagnosis of 
depression [24]. 
Depressed patients, compared to healthy 
controls, have an elevated white blood cell count. A 
high white count is called leukocytosis. The white 
blood cells (leukocytes) include all of the immune cells 
found in the blood; consequently, leukocytosis is a 
reliable sign of an activated immune system [24]. 
Increased numbers of monocytes in the blood 
(called monocytosis) of depressed patients were first 
reported by Maes et al. and recently confirmed by 
Seidel et al. Monocytes are found in the blood, which 
makes them easy to sample and measure. They are 
the chief source of IL1, IL6, TNF and INFα in the 
blood [25] [26]. 
Monocytes migrate from the blood into solid 
tissues where they are transformed into 
macrophages. Macrophages never return to the 
blood. This means they are rarely evaluated in 
humans because almost all immune system analyses 
are done on blood. Nevertheless, in animal 
experiments, whenever there is monocytosis, there is 
macrophage activation someplace in the body. Thus, 
the monocytosis exhibited by depressed patients 
indicates that macrophages are activated someplace 
in their bodies [24]. 
Maes two papers on monocytes cited above 
also found high levels of neutrophils (a condition 
called neutrophilia) in the blood of depressed patients. 
The most severely depressed individuals had the 
highest numbers of neutrophils. Neutrophils, the most 
plentiful of the white blood cells, are members of the 
inflammatory arm of the immune system. Neutrophilia 
is a well-established sign of immune system 
activation. Thus the discovery of neutrophilia in 
depression is another persuasive piece of evidence 
showing that depressed individuals have activated 
immune systems [24]. 
The total number of lymphocytes does not 
appear to be increased in depressed patients. 
Nevertheless, within the various types of lymphocytes, 
there are very important changes. In a recent study by 
Maes et al., of 106 subjects, there was a significantly 
increased number and percentage of B-lymphocytes 
in depressed subjects compared to controls [27]. This 
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was confirmed in another study of depressed patients 
[28]. B-lymphocytes are the antibody-producing cells. 
(They are called B-lymphocytes because they are 
matured in bone.) Increased numbers and 
percentages of B-lymphocytes are clear signs of 
immune system activation [24]. 
The T stands for the fact that these 
lymphocytes mature in the thymus. By secreting 
regulatory cytokines like IL-2 and INFγ, T-lymphocytes 
exert remarkable control over immune system activity. 
Immunologists have identified many different types of 
T-lymphocytes. Two of the most important is the T-
helper lymphocytes (these are identified by the so-
called CD4 antigen on their cell surface) and the T-
suppressor lymphocytes (these are identified by the 
so-called CD8 antigen on their cell surface) [24]. 
Maes et al., in one of his many landmark 
papers on depression, reported extraordinarily 
consistent evidence of T lymphocyte activation in 
depressed patients. Healthy controls were compared 
to 101 depressed inpatients consecutively admitted to 
the Psychiatric Ward of the University Hospital of 
Antwerp. Depressed patients had significantly higher 
percentages of T-helper lymphocytes and lower 
percentages of T-suppressor lymphocytes than 
healthy controls. The T-helper/T-suppressor ratio was 
significantly elevated in depressed patients. The 
patients with the most severe depression had the 
highest percentage of T-helper lymphocytes and the 
highest T-helper/T-suppressor ratio [28]. 
A high percentage of T-helper lymphocytes 
combined with the finding of monocytosis in 
depression means that both the lymphocyte and the 
macrophage arms of the immune system are 
activated. The reduced percentage of T-suppressor 
lymphocytes is another clear sign of the immune 
system is energised. The high T-helper/T-suppressor 
ratio is a reliable indicator of immune system 
activation. In the same paper, Maes et al. provided 
additional evidence of lymphocyte activation [28]. 
Recently Müller et al. investigated the 
lymphocyte subsets of severely depressed patients. 
Their results were very similar to Maes et al. 's 
findings. Müller et al. 's paper provided independent 
confirmation of over-active immune systems in 
severely depressed patients. Several earlier papers 
by other scientists have also reported a high T-
helper/T suppressor ratio in depressed patients [29]. 
Another reliable sign of lymphocyte activation 
in the presence of interleukin2 receptors on the outer 
surfaces of lymphocytes. Maes et al. reported that 
increased interleukin2 receptors on lymphocytes are a 
hallmark for major depression. This is further 
independent evidence of immune activation with 
depression [30]. 
The usual antibodies made by activated B-
lymphocytes will clump and identify foreign proteins. 
As soon as a foreign protein is tagged with an 
antibody, it will be devoured by macrophages and 
killer lymphocytes. In this way, the immune system 
can quickly identify and destroy foreign invaders. In 
sharp contrast, autoantibodies, clump and identify 
self-proteins (that is, proteins which are an integral 
part of your own body). Self-proteins, after they are 
tagged with autoantibodies, will be attacked and 
devoured by macrophages and killer lymphocytes. In 
other words, when autoantibodies are produced, the 
immune system begins attacking the very body it is 
supposed to defend. Diseases which are caused by 
the immune system attacking the body are called 
autoimmune diseases. Another profound similarity 
between depression and autoimmune disease is the 
very high incidence of depression with autoimmune 
diseases.  
Typically, biomedical scientists either have no 
explanation for the high rates of depression occurring 
with autoimmune diseases or very convoluted 
explanations. In sharp contrast, the immune-cytokine 
model of depression has a clear and direct 
explanation, i.e., the activated immune systems in 
persons with autoimmune disease secrete excessive 
amounts of cytokines. Excessive cytokines provoke 
the symptoms and signs of depression [31]. 
Evidence suggests that these associations 
can be affected by a) the clinical characteristics of 
depression (e.g., typical depression versus atypical 
depression and exhaustion), b) the duration and 
severity of depressive symptoms, and c) the stage of 
an underlying CAD. Depressive symptoms are 
hypothesised to affect the transition primarily from 
stable CAD to acute coronary syndromes via plaque 
activation and prothrombotic processes and may play 
an additional role in response to injury at early stages 
of coronary atherosclerosis [24]. 
Type D personality is a behavioural model in 
which people experience negative emotions such as 
depression, anger, hostility and anxiety while they 
refuse to express it. Denolt (2000) identifies type D 
personality in the long-term by an increased risk of the 
first myocardial infarction [32]. Type D personality can 
lead to increased fatigue or depression among the 
people with such a personality type. Therefore, these 
factors will be correlated with increase reactivity to 
acute stresses [33].  
Type D personality is specified by a 
combination of two fixed personality structure: 
negative affectivity and social inhibition [34][35]. 
Negative affectivity is the tendency to experience 
negative emotions constantly such as restlessness, 
boredom, fear and irritability in all times and 
situations. Social inhibition is the intendancy to inhibit 
expressing the emotions, high levels of insecurity 
experience in social situations and extreme control of 
self-revelation for fear of others’ displeasures [32]. 
Type D personality is relatively common. The 
estimations show a range of 21-28% of cardiovascular 
patients and 53% of the people with high blood 
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pressure among the public population [35] [36]. Type 
D personality theorists believe that the synergistic 
effect of high negative affectivity and high social 
inhibition predict less health and especially poor 
prognosis in the heart [34]. 
Previous studies indicate that type D 
personality predicts severe heart disease and it may 
be associated with psychological and physiological 
indicators of poor prognosis in patients with heart 
disease [37] [38]. Type D personality is parallel to 
psychological distress in patients with CHD including 
signs of social alienation, depression, anger, anxiety, 
paranoia and vital exhaustion [39]. The patients with 
type D are more likely to commit maladaptive health 
behaviours such as smoking and a poor diet. The 
people with type D personality use the solutions for 
dysfunctional coping strategies in response to disease 
[40]. Therefore, type D personality can lead to a 
poorer prognosis by affecting the selection of lifestyles 
among the patients with CVD [41]. Also, the studies 
show the relationship between anger (as one of the 
negative affectivity components in type D personality) 
and the increased cardiovascular diseases [42] [43]. 
Type D individuals tend to experience 
negative emotions such as depressed mood, anxiety, 
anger, hostile feelings, and to inhibit these emotions 
while avoiding social contacts [44] [45] [46]. Situations 
involving fear, anxiety, helplessness, and loss of 
control result in the release of cortisol [47] [48]. The 
relationship between negative affect and cortisol 
activity has been documented in several studies using 
structured laboratory stressors, such as public 
speaking and mental arithmetic [49] and aversive 
stimulation [48], and in the scientific literature related 
to changes in the hypothalamic-pituitary-adrenal 
(HPA) axis in depressed patients [50] [51]. A recent 
study has documented relationships between negative 
affect, positive affect and cortisol in response to 
naturalistic stressors [52]. Both the experience of a 
current stressor and anticipating a stressor were 
associated with increased salivary cortisol levels. 
Negative affect was associated with higher cortisol 
levels, and positive affect was associated with lower 
cortisol levels. Another study also found that stressful 
daily events were associated with increased cortisol 
secretion in healthy volunteers [53]. Distress, as 
reflected by the mood states ‘negative affect’ and 
‘agitation’, was associated with higher cortisol levels. 
Mood plays a mediating role in the relationship 
between stressful events and cortisol secretion [52] 
[53]. Negative affectivity is not just a confounder but is 
related to elevated cortisol secretion during normal 
daily activities. In a recent study, both type D 
dimensions (negative affectivity and social inhibition) 
were associated with greater cortisol reactivity to 
stress [46], although the results were not significant in 
more stringent regression analyses. However, it is 
reasonable to suggest that there is a difference in 
HPA regulation in type D individuals and people with 
other personality types. 
Depression appears to be an independent risk 
factor for the development of coronary heart disease 
and osteoporosis and affects the prognosis of these 
and other medical disorders [54] [55]. Considerable 
evidence suggests an association between 
depression and hypertension, peptic ulcers, and 
diabetes [54] [55]. Elevated cortisol may be a 
mediating factor in these relationships. Cortisol has 
many effects that promote coronary heart disease. For 
example, cortisol inhibits the growth hormone and 
gonadal axes. Growth hormone deficiency is 
associated with a higher relative risk for premature 
cardiovascular disease in adults [56] [57]. Cortisol is a 
potent stimulus to visceral fat. Inhibition of the growth 
hormone and gonadal axes exacerbates visceral fat 
accumulation. Excess visceral fat leads to 
dyslipidaemia and, along with hypercortisolism, to 
insulin resistance, hyperinsulinism, and their sequelae 
[58]. Similar mechanisms may increase the 
vulnerability of type D individuals to cardiac and other 
medical illnesses. Elevated cortisol may be a 
mediating factor in the association between type D 
personality and the increased risk for coronary heart 
disease and, possibly, other medical disorders. It is 
important to note that cortisol is not the only mediating 
factor in this association. A recent study suggests that 
type D personality is associated with increased 
circulating levels of cytokine tumour necrosis factor α 
and its soluble receptors 1 and 2, which are predictors 
of mortality in chronic heart failure [59].  
Depression is associated with impairment in 
feedback control of the HPA axis, contributing to 
higher cortisol levels during episodes of depression 
[50] [60]. Prolonged exposure to elevated cortisol 
levels may be neurotoxic, especially for brain regions 
rich in corticosteroid receptors, and may mediate 
neuronal vulnerability to stressors. Recurrent 
depression is associated with atrophy of the 
hippocampus and amygdala [61] [62] as well as the 
prefrontal cortex [63]. A gradual deterioration of 
hippocampal feedback inhibition of the HPA axis due 
to down-regulation of glucocorticoid receptors from 
repeated stress has been demonstrated [64] 
[65]. Evidence suggests that age and/or length of 
depression and/or the number of depressive episodes 
affect HPA regulation in depressed patients [51] [61] 
[62]. The potentiating or additive effect of age in 
conjunction with depression on pituitary-adrenocortical 
activity was suggested by some studies [51] [62] 
[67]. Mean 24-h cortisol level increases with age in 
depression [68]. Elderly depressives who are cortisol 
non-suppressors after dexamethasone need more 
time for pituitary adrenocortical normalisation to occur 
than do younger subjects [69]. An increase in post-
dexamethasone cortisol levels with age has been 
reported in major depressive disorder [70]. A 
significant effect of age on cortisol release in 
depressed patients has been observed during the 
combined dexamethasone-corticotropin-releasing 
hormone test: older patients had higher post-
dexamethasone cortisol levels [71]. In patients with 
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endogenous depression, advancing age leads to 
higher baseline cortisol and a greater likelihood of 
being a dexamethasone non-suppressor [72]. Cortisol 
responses to fenfluramine administration in depressed 
patients increased with the number of major 
depressive episodes [51]. Other authors have 
reported similar observations [66] [68] [73]. However, 
some authors suggest that age does affect HPA 
regulation in healthy humans [74] [75]. Differences in 
the results of studies have been be explained by 
differences in a sample size, screening criteria, and 
some other factors, such as differences in sleeping 
patterns [51] [76].  
Equivocal results of these studies may be, in 
part, related to a different prevalence of type D 
individuals in study samples: i.e. some type D 
individuals may have alterations within the HPA axis 
that are similar to HPA axis changes in depressed 
patients [77]. Future studies of HPA function should 
control for the presence of type D individuals. Type D 
individuals should perhaps not participate in 
psychobiological studies as healthy controls. Studies 
of HPA function should also control for other 
personality traits that may affect the HPA axis. For 
example, individuals with borderline or antisocial 
personality features may have HPA axis abnormalities 
[78] [79] [80].  
 
 
Results 
 
To clarify the discussion, it is necessary to 
have a glance at some studies associated with 
psychological risk factors including depression, stress 
and type D personality on CAD. The stress is also 
addressed by plenty of researchers. Lots of studies 
report changes in quantity and ratio of T and B cell as 
well as changes in Natural Killer (NK) Cells and 
cykotines and failure in functional responses due to 
acute psychological stresses. Nevertheless, recent 
studies often focus on the relationship between street 
with other psychological factors and inflammatory 
markers [34].  
Bosch et al. (2003) show a considerable 
amount of Chemokine receptor incidence by T cells 
caused by induced stress [81]. Mills et al., (1995) 
show that immune responses caused by stress are 
strengthened among the people with high blood 
pressure [82]. Besides, Fuligni et al., (2009) show an 
increased CRP level due to increased experience of 
daily stresses, considering CRP as one of the 
inflammatory indices for cardiovascular diseases [83]. 
Benson et al., indicate that acute stress leads to a 
significant increase of CRP and IL-6 in fat women 
[84]. Steptoe et al. (2007) conclude, in a review study 
on interface mechanisms between psychological 
factors and cardiovascular diseases risk that IL-1 and 
IL-6 increase after acute stress [9].  
Also, Mommersteeg et al., (2008) indicate the 
relationship between hostility and Cytokine/ 
Chemokine clusters [85]. They also confirm the 
relationship between hostility and increased 
proinflammatory and anti-inflammatory cytokines [85]. 
Bacon et al., (2006) address that mental stress leads 
to heart pain and myocardial ischemia among the 
patients with cardiovascular patients [86]. Decreased 
plasma volume may be a mechanism by which 
potential mental stress is increased for acute 
cardiovascular events [87]. Bosch et al., (2003) also 
show that acute stress causes to move T cells which 
were initially induced for response to inflamed 
endothelium [81]. Acute stressors can help to absorb 
circulation of immune cells under endothelium and 
hence to accelerate plaque formation and lead to the 
effects caused by acute stressors. This mechanism 
can help to express the relationship between stress 
and cardiovascular diseases [88]. 
Also, the depression risk factor is addressed 
by plenty of researchers. Masselman and Freedland 
(2002) show biological processes associated with the 
role of depression on CHD risk in women [89]. They 
conclude that the depression causes to increase 
blood pressure and also elevate the risk of coronary 
arteries occlusion by platelet aggregation and 
accumulation of steroid hormones [89]. Ladwig et al., 
(2003) and Miller et al., (2003) show both the 
relationship between depressive disorders and 
inflammation markers as well as significant relations 
among the people with overweight [90] [91]. Miller et 
al., (2003) use Structural Equation Modeling to 
determine the role of leptin regarding depression, 
obesity and CRP and IL-6 markers. Von Kanel et al., 
(2008) indicate that depression signs-as one of the 
cardiovascular diseases risked factors-predict 
increases TNF-α level and decreased IL-4 as well as 
the elevated ratio of IL-4 to TNF-α [92]. Ranjit et al., 
(2007) show, in a study on psychosocial risk factors 
for cardiovascular disease, the positive relationship 
between severity of depression and an increase of IL-
6 level [93]. Personality type risk factor is also studied 
in several papers. Denollet et al., (2003) address type 
D personality for chronic negative affectivities and 
present some evidence on increased TNF-α among 
the patients with congenital heart failure having type D 
compared to those without type D [94]. Gridon et al., 
(2003) investigate the conventional chemical indices 
among the admitted patients without acute coronary 
syndromes and observe that chronic psychological 
risk factors are associated with increased white blood 
cell count and lymphocyte percentage [95]. Pedersen 
and Middel (2001) recognised type D personality 
independent of such factors as disease severity and 
argue it causes to increase the risk of bad prognosis 
up to 2-5 times, decrease life quality and arise factors 
of stress and depression [96]. 
Although there exists low information about 
harmful impacts of type D personality in clinical 
results, these can be some possible causes: immune 
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system, the behaviours associated with health 
including smoking and refusal of medical commands. 
Pederson et al., (2004) the study impact of type D 
personality on the occurrence of side effects among 
the patients with Ischaemic Heart Disease (IHD) after 
Percutaneous Coronary Intervention (PCI) by 
Sirolimus-Eluting Stent (SESs) or Bare Metal Stent 
(BMSs) for nine months [97]. Regardless of the stent 
type, the patients with type D personality are more 
likely to be on the subject of death and MI compared 
to those without type D personality for nine months 
[97]. The patients with depression or type D 
personality are in the subject of the risk of improper 
response to treatment by the stent. The patients with 
type D personality often expect unsuitable clinical 
consequences in IHD along with Left ventricular 
dysfunction [97]. 
Also, some studies focus on stem cells. 
Recent studies in this regard have expanded our 
knowledge on Haematopoietic Stem Cell (HSC) 
niches which are important to maintain and conduct 
renewal and differentiation the HSC. Osteoblasts, 
Mesenchymal Stem Cells (MSCs) and CXCL12-
Abundant Reticular (CAR) cells are components of the 
bone marrow microenvironment and are associated 
with HSCs which are specified in the performance of 
body immune system and Homeostasis. It is 
noteworthy to say that cell populations of the bone 
marrow microenvironment send a message for 
different and proper functions of the immune system 
through G Protein-Coupled Receptors (GPCRs) [98].  
MI is the main mortality cause in industrial 
countries. Therefore, stem cells-based therapeutical 
approaches are an important necessity for MI in 
Regenerative Medicine and coronary arteries. The 
experimental studies show that stem cells derived 
from Bone marrow endothelial progenitor cells can 
improve the coronary performance after Myocardial 
Infarction. Phases I and II studies started quickly to 
transfer these concepts to the clinical stage. However, 
impacts of stem/ progenitor cells on MI in a clinical 
stage have not met the expectations so far. Therefore, 
a better understanding of the common limitation 
causes is necessary for cell therapy approaches. It is 
again noteworthy to mention that quantity and 
performance of endothelial progenitor cells is 
decreased among the patients with cardiovascular risk 
factors or CAD. These observations may provide the 
opportunities to optimise and amend cell therapy 
approaches. In present review study, a summary of 
current evidence on the role of stem/progenitor cells in 
pathophysiology and treatment of ischemic diseases 
is presented including properties of the cells, 
regeneration capacity in the colony of stem/progenitor 
cells. Also, stem/progenitor cells delivery methods, 
their implantation adjustment as well as potential 
approaches to start employment of stem/ progenitor 
cells in cell therapy methods are explained for 
cardiovascular diseases [99].  
While the requests are increasing 
considerably for effective therapeutic choices for 
chronic coronary failure, the recent identification of 
physiologic and pathologic changes of myocytes in 
the adult human’s heart has presented the 
fundamental base of regeneration therapy. Different 
methods have been represented experimentally in this 
regard among which some selected cases were used. 
This history starts with skeletal myoblasts and bone 
marrow-derived cells and then proceeds already with 
stem/Mesenchymal stromal cells inside the heart. 
Among them, C-KIT (positive) cardiac stem cell 
transplantation caused leading results with long-term 
impacts without side effects in the patients with 
chronic ventricular dysfunction. For more optimisation 
of present methods, we should identify different 
factors including the target disease, cellular population 
and quantity of injected cells as well as cell transfer 
method. Identification of former clinical tests results 
allows us to predict an ideal cell therapy for different 
cardiovascular disorders [100]. 
 
 
Discussion 
 
The connection between heart and mind is a 
deep and prolonged bond. Advances in modern 
behavioural medicine have shifted psychology 
specialists towards the key role of abiotic factors in 
CHD. The researches on this disease have paid 
psychological factors into attention for a while, and the 
relationship between immune system parameters and 
psychological factors is an important topic of today 
studies on the progression of a CAD. In this regard, 
the present study aimed to investigate the effect of 
three psychological factors including depression, 
stress, and Type D personality on the immune system 
in coronary artery disease. Generally, the research 
findings discussed in this review confirm the validity of 
the hypothesis that psychoneuroimmunologic 
processes involved cardiovascular diseases. A set of 
these findings which have been published earlier are 
based on hypotheses about the potential role of 
psychoneuroimmunologic pathways in the 
pathogenesis of cardiovascular diseases. 
Figure 2 which is derived from Kop’s theory 
shows three categories of psychological factors 
(acute, episodic and chronic), immune system 
parameters related to CAD progression and 
progression stages of heart diseases and pathologic 
changes/lesions in coronary arteries, respectively 
from left to right [7]. As it can be seen at the right edge 
of the figure, the initial stages of coronary 
arteriosclerosis are specified by monocytes deposition 
in arteries wall that in this process, adhesion 
molecules play an important role. In the next stages of 
CAD, cytokines involved in the activation of T cells 
and the formation of macrophage foam cells. In this 
stage, the performance of Endothelial will diminish 
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and thereby its dilation, and contractile properties will 
be lowered to respond to blood flow and other arteries 
vasodilatation stimuli. 
After initial vascular lesions, Smooth muscle 
cells will proliferate and migrate to plaque surface and 
finally contribute to form a fibrous coating with a stable 
ration on atherosclerotic lesions. In severe CAD 
mode, several factors may cause to stimulate the 
plaque and result in lesion instability and thinning of 
the fibrous coating. The plaque rupture leads to partial 
or complete occlusion of coronary arteries. This lesion 
often is caused by thrombus formation resulting from 
blood contact with collagen. Sudden occlusion of 
coronary arteries can cause cardiac ischemia and 
chest pain while complete and continuous clotting 
results in myocardial infarction [101] [102]. More 
precise studies on this complex process can be 
followed up in several types of research. 
Psychological risk factors are effective through 
differentiated immunologic processes in the 
pathophysiological trend of heart. 
Pathophysiologic mechanisms involved in 
stress include Catecholamines increase due to the 
sympathetic nervous system, increased heart rate and 
blood pressure, decreased plasma volume and 
coronary vasoconstriction [86]. Immune system 
responses to stress can potentially help 
Atherosclerotic plaque rupture. Most of the studies on 
psycho-immunology show increased CD8+ cells and 
decreased CD4+ cells, as well as increased blood 
viscosity and stimulating the immune system in 
response to acute psychological challenges [7] [9]. 
These responses are the same as acute phase 
reactivity and relate to Hemodynamic responses to 
acute stresses [1]. 
 
Figure 2: Acute, episodic and chronic psychological risk factors 
model by the immune system parameters involved in Coronary 
Arteries Disease 
 
The value of depression- as the predictor 
variable for unsuitable long-term cardiac 
consequences- relates to its relapsing nature [1] [103]. 
In major depression, secretion of Corticotropin-
Releasing Hormone (CRH) and repeated activation of 
HPA axis and thereby irregularity in this axis are seen 
[103] [104] [105]. Since psychological risk factors of 
depression have temporary nature. In most of the 
studies, no significant correlation is found between 
these factors and CAD severity [103]. Therefore, the 
processes involved in atherosclerotic plaques 
transition from stable to unstable mode are the 
probable factors which contribute on the formation of 
predictor role for depression and other episodic 
factors in acute coronary syndromes [1] [6] [106]. 
Immunologic correlates of depression include 
increased leukocytes of peripheral blood (mainly 
neutrophils and monocytes), decreased lymphocyte 
count, elevated serum cytokines (IL-6 and TNF-α), 
reduced indices of cell function and increased viral 
antibodies (e.g. cytomegalovirus) [7] [106]. 
Stable conditions such as type D personality 
are related to increased risk of first myocardial 
infarction in a long-term period [107]. Pro-atherogenic 
processes-which cause to increase lipid deposition 
and inflammatory processes due to the sympathetic 
nervous system-are of the well-known 
pathophysiologic pathways among chronic risk factors 
and initial stages of CAD [7]. Also, chronic 
psychological factors involved in the appearance of 
episodic risk factors. For instance, these factors can 
be associated with an increased incidence of 
depression or exhaustion [104]. Therefore, the 
prediction power of chronic psychological factors is 
somewhat influenced by their relation with episodic 
and acute [sychological risk factors for CAD. Kop 
refers to Jeron et al., in which neurohormones are 
proved as the potential factors for cytokine myocardial 
(IL-6) adjustment using an experimental model [7]. 
Regarding the mechanism of type D 
personality components effectiveness on coronary 
arteries narrow, the effects they make on the coronary 
system can be referred. Negative affectivity causes to 
increase Cortisol levels. Therefore, the people who 
experience negative affectivities are more prone to 
increased blood pressure and heart failure. In other 
words, stress hormones like Cortisol may be adjusted 
unsuitably among the patients with type D personality 
[43] [108]. This leads to increase blood pressure and 
blood vessel blockages. The arteries occlusion does 
not allow the blood full of oxygen to reach sufficiently 
the heart. On the other hand, the patients with type D 
personality may have a more active immune system 
with more inflammation which may damage blood 
vessels. 
Briefly, the present study aimed to describe 
psychoneuroimmunological processes which 
contribute to CAD and CHD progression. Such 
psychological risk factors as stress, depression and 
type D personality were investigated here. 
Psychoneuroimmunological pathways of all three 
mentioned risk factors were described for CAD. The 
studies review indicated that stress could be 
accompanied with myocardial ischemia and help to 
rupture. The depression involves in the transfer of 
stable atherosclerotic plaque to unstable, and type D 
personality is effective on initial stages of a CAD.  
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However, most of the statistical indices in this 
regard have a small effect size which is likely to be 
due to the role of different risk factors role in 
cardiovascular disease progression. Therefore, more 
researches are required on psycho-immunological 
mechanisms along with other cardiovascular risk 
factors including blood pressure, obesity, insulin 
resistance and age. Several studies in this regard 
show that other risk factors play as contributors in the 
relationship between psychological factors and 
immune system parameters associated with CAD [7]. 
As a result, some studies should be carried out by 
advanced methodologies including structural 
equations modelling. Also, to show clinical application 
of the reported relations, longitudinal studies are 
proposed to be conducted. Future clinical measures 
and researches on the integration of cardiovascular 
behavioural medicine and psycho-immunology can 
lead to increase classification accuracy of vulnerable 
patients as well as potentially improve intervention 
strategies. 
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